NACSELD 2

Determine the prognosis of inpatients with cirrhosis admitted non-electively regardless of infection.


Focus: Outcomes, Definition of ACLF, Individual Organ Failure, Quality Control, & Translational Analysis.

Steering Committee

  • Jasmohan S Bajaj, MD

    Virginia Commonwealth University, Richmond, VA

  • K Rajender Reddy, MD

    University of Pennsylvania, Philadelphia, PA, USA

  • Jacqueline G O’leary, MD

    Baylor University Medical Center, Dallas, TX, USA

  • Florence Wong, MD

    University of Toronto, Toronto, Canada

  • Guadalupe Garcia-Tsao, MD

    Yale University, New Haven, CT, USA

  • Patrick S Kamath

    Mayo Clinic, Rochester, MN, USA

Participating Sites & PIs

  • University of Alberta, Edmonton, Canada

    Puneeta Tandon, MD

  • University of Rochester, Rochester, NY

    Benedict Maliakkal, MD

  • University of Colorado, Denver, CO

    Scott W Biggins

  • University of Texas, Houston, TX

    Michael Fallon

  • Mercy Medical Center, Baltimore, MD

    Paul Thuluvath

  • Emory University, Atlanta, GA

    Ram Subramanian

  • University of California, San Francisco, CA

    Jennifer C Lai, MD

  • Mayo Clinic, Phoenix, AZ

    Hugo E Vargas, MD

Data & Biorepository

  • VCU Data Coordinating Center, Richmond, VA

    Centralized Study set up at Richmond Institute for Veterans Research, Richmond, VA

Consortium
Publications

Meeting Abstracts